✦ LIBER ✦

De novo CD5+ diffuse large B cell lymphoma with basophilia in the peripheral blood: Successful treatment with autologous peripheral blood stem cell transplantation

✍ Scribed by Michihide Tokuhira; Reiko Watanabe; Atsushi Iizuka; Yasunobu Sekiguchi; Tomoe Nemoto; Kyoko Hanzawa; Ichiro Takamatsu; Taro Maruyama; Jun-ichi Tamaru; Shinji Itoyama; Hiroshi Suzuki; Tsutomu Takeuchi; Shigehisa Mori

Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 529 KB
Volume: 82
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.20786

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Successful umbilical cord blood transpla

Successful umbilical cord blood transplantation in an infant with ALL failing initial autologous peripheral blood stem cell transplantation

✍ Shimokawa, Tatsuo ;Ohashi, Hiromi ;Takaue, Yoichi ;Kawano, Yoshifumi ;Abe, Takan 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB

Peripheral blood and bone marrow finding

Peripheral blood and bone marrow findings in B-cell lymphoma, unclassifiable with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma

✍ Osman S. Ahmad; Keith Fishlock; Philippa May; Ed Kanfer; Kikkeri N. Naresh 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB 👁 2 views

Comparison of allogeneic stem cell trans

Comparison of allogeneic stem cell transplantation, high-dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with de novo acute myelogenous leukemia

✍ Apostolia-Maria Tsimberidou; Niki Stavroyianni; Nora Viniou; Maria Papaioannou; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views

## Abstract ## BACKGROUND Postremission therapy is critical in maintaining complete remission (CR) in patients with de novo acute myelogenous leukemia (AML). The aim of this trial was to compare allogeneic stem cell transplantation (SCT), high‐dose cytarabine (ara‐C; HiDAC), and autologous SCT as

Successful long-term control with lamivu

Successful long-term control with lamivudine against reactivated hepatitis B infection following intensive chemotherapy and autologous peripheral blood stem cell transplantation in non-Hodgkin's lymphoma: Experience of 2 cases

✍ Masashi Nakagawa; Yoshifumi Simizu; Masaki Suemura; Bunzo Sato 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 3 views

## Abstract It is well documented that cytotoxic treatment in patients carrying the hepatitis B virus (HBV) enhances the risk of severe hepatic damage. Recently lamivudine has been reported to be effective in suppressing the replication of HBV under such conditions. Here we report two cases with HB

TCR-Vβ repertoire analysis with RT-PCR w

TCR-Vβ repertoire analysis with RT-PCR was useful for the early detection of pulmonary relapsed T-cell lymphoma after autologous peripheral blood stem cell transplantation

✍ Hase, Hidenori; Tani, Kenzaburo; Nagayama, Hitomi; Watari, Kiyoshi; Takahashi, S 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 1 views

Pulmonary recurrence of malignant lymphoma is a rare event after stem cell transplantation. We report here a 45-year-old male who was successfully diagnosed with relapsed pulmonary T-cell lymphoma using an RT-PCR method. Clonal expansion of T cells expressing identical TCR V-D-J junction size (V␤5-J

High-dose therapy and autologous periphe

High-dose therapy and autologous peripheral blood stem cells transplantation followed by a very low reduced intensity regimen with fludarabine + cyclophosphamide and allograft improve complete remission rate in de novo multiple myeloma patients

✍ Massimo Martino; Giuseppe Console; Giuseppe Irrera; Giulia Praticò; Caterina Ste 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB 👁 2 views

## Abstract The recent development of reduced intensity conditioning and allotransplantation (RICT) has opened a new way to assure engraftment of donor cells while reducing early transplant‐related mortality. We evaluated the combination of high‐dose therapy and autologous peripheral blood stem cel